Diabetes Obes Metab 19:16691680 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial
Recognizing phase one and two detox pathways via nutrigenomics allows precise supplementation strategies
19 KishorP
Several amino acids have been demonstrated to stimulate GLP-1 release in vivo and in vitro, however, there are discrepancies between the reported stimulatory capacities of individual amino acids [40,41,42,43,44,45,46]